High-priced prescription drugs have been making headlines for years, but soaring insurance premiums have put drug costs back in the spotlight. Ryan Mcguire, Rochelle gagg and adam Bianchi at Cutting Edge Info discuss how executives from nearly every pharmaceutical company consistently cite the same three justifications for high costs.
 
http://jforcs.com/jcs/wp-content/uploads/2013/08/2-New-Understading-and-New-Tools-to-Improve-the-Effectiveness-of-Oncology-Clinical-Development-and-Potencially-Reduce-Drug-Costs2.pdf